These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6168462)

  • 1. [Oncofetal proteins in diagnosis of fetal malformations and cancer].
    Seppälä M
    Duodecim; 1981; 97(10):652-62. PubMed ID: 6168462
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases].
    Arbuzova SB; Nikolenko MI
    Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fetal malformations and alpha fetoprotein. Experiences in the Canton of Waadt].
    Pescia G; Weihs D; Nguyen-The H
    Gynakol Rundsch; 1983; 22 Suppl 3():48-53. PubMed ID: 6187633
    [No Abstract]   [Full Text] [Related]  

  • 4. Information from your family doctor. Triple screening in pregnancy--what it is and what to expect.
    Am Fam Physician; 2002 Mar; 65(5):922. PubMed ID: 11898966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pregnancy-specific beta 1-glycoprotein, HCG alpha subunit, alpha fetoproteins and HPL in fetal hypotrophy].
    Ruseva R; Marinov B; Milkov V; Milanov S
    Akush Ginekol (Sofiia); 1984; 23(4):315-20. PubMed ID: 6207743
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alpha fetoprotein in the diagnosis of fetal abnormalities].
    Melchert F; Kreienberg R
    Arch Gynecol; 1979 Jul; 228(1-4):202-3. PubMed ID: 90483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening for serum alpha-fetoprotein for the detection of congenital malformations in the 16-18th weeks of pregnancy. Results of 24,023 pregnancy screenings].
    Pedersen BN; Bagger PV; Bang J; Fischer-Rasmussen W; Gad C; Hasch E; Helkjaer PE; Jacobsen JC; Kjeldsen J; Kjaersgaard E
    Ugeskr Laeger; 1984 Oct; 146(43):3253-9. PubMed ID: 6209838
    [No Abstract]   [Full Text] [Related]  

  • 8. Using ultrasonography to diagnose fetal malformations.
    Bowerman RA
    J Reprod Med; 1982 Sep; 27(9):560-4. PubMed ID: 6183423
    [No Abstract]   [Full Text] [Related]  

  • 9. Prenatal diagnosis using the triple test.
    Palka G; Guanciali Franchi P; Papponetti M; Marcuccitti J; Morizio E; Calabrese G; Stuppia L; Di Ilio C
    Minerva Ginecol; 1998 Oct; 50(10):411-5. PubMed ID: 9866951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maternal serum screening for detection of fetal chromosome abnormalities].
    Holzgreve W; Miny P; Schloo R; Tercanli S
    Gynakologe; 1995 Oct; 28(5):280-8. PubMed ID: 7498824
    [No Abstract]   [Full Text] [Related]  

  • 11. Antenatal screening for fetal abnormalities.
    Jolley J
    Radiography; 1984 Jan; 50(589):14. PubMed ID: 6198674
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical scope. Fetal abnormalities and their recurrence].
    Shimada N
    Josanpu Zasshi; 1980 Dec; 34(12):844. PubMed ID: 6162979
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical uses of maternal serum markers in the prenatal diagnosis].
    Li G; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):252-4. PubMed ID: 10682475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mass screening for fetal defects?].
    Boman H
    Tidsskr Nor Laegeforen; 1990 Sep; 110(22):2859-60. PubMed ID: 1699296
    [No Abstract]   [Full Text] [Related]  

  • 15. [Specific sonographic exclusion diagnosis of fetal abnormalities in risk groups].
    Hansmann M; Gembruch U
    Gynakologe; 1984 Mar; 17(1):19-32. PubMed ID: 6202588
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple marker screening.
    Dickerson VM
    West J Med; 1994 Aug; 161(2):161. PubMed ID: 7524245
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disorders of fetoplacental function in pregnant women with diabetes].
    Mikulíková L; Struplová J; Fialová L; Malbohan I
    Sb Lek; 1993; 94(2):173-7. PubMed ID: 7527583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
    Hogge WA; Fraer L; Melegari T
    Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present role of diagnostic ultrasound in prenatal diagnosis of congenital abnormalities.
    Wladimiroff JW; Niermeijer MF; van Egmond-Linden A; Jahoda M
    Prog Clin Biol Res; 1982; 103 Pt B():539-60. PubMed ID: 6187022
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in the prenatal diagnosis of congenital diseases.
    Hirschhorn K
    Monogr Pathol; 1981; (22):49-51. PubMed ID: 6168905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.